SUMMARY The selectively toxic effect of nitroimidazole drugs towards anaerobic bacteria and protozoa depends on a number of factors. The killing action of such drugs as metronidazole requires the reduction of the nitro group, a process which influences the rate of entry of the drug into the susceptible cell and which is determined by mechanisms involving ferredoxin-linked (or the equivalent) reactions in the cell. The reduced agent subsequently causes strand breakage of DNA, the extent of which depends on the A + T content of the DNA. Other effects of such drugs may include the possible inhibition of DNA repair mechanisms which exacerbate DNA damage. Inhibition of activity of nitroimidazoles may be caused by aminothiol radical scavengers and radioprotectors normally present in the cell or by the presence of other organisms in the environment (that is, the vagina) capable of inactivating the drugs.
Introduction
In 1978, an editorial in this journal' gave a short review of the types, availability, and relative activity of nitroimidazoles used primarily against Trichomonas vaginalis infections. It is now timely to review the mechanism of action of such drugs in an attempt to explain their selective action and their unique contribution to the chemotherapy of anaerobic organisms since their introduction in 1959.
The first of these drugs, metronidazole, has been studied more widely than any other and consequently will be used as the type example. Metronidazole (I-p-hydroxyethyl-2-methyl-5-nitroimidazole) is effective against a variety of protozoal diseases including trichomoniasis,2 giardiasis,3 amoebiasis,4 and balantidiasis,5 as well as being a valuable agent for the treatment of bacterial disease caused by anaerobes-for example, Vincent's disease6 and post-operative infections.7 I More recently, much interest has been shown in its possible application as a specific radiosensitiser of hypoxic tumours together with the 2-nitroimidazole, misonidazole.9- '3 Other nitroimidazole drugs, such as tinidazole, sulnidazole, secnidazole, and ornidazole, have broadly similar spectra of activity but none has sufficient advantages to supplant metronidazole from its role as the drug of choice for many bacterial and protozoal diseases. The structure of the drugs is shown in the figure. The spectrum of activity of nitroimidazoles is unique in that unlike any other antimicrobial drug they encompass Gram-positive and Gram-negative bacteria, protozoa, and even a few nematode worms, all of which are either anaerobic or micro-aerophilic. Thus the selective toxicity of these drugs rests on their ability to exert a cytotoxic effect specific to anaerobes.
Mode of action
The first studies on the mode of action of metronidazole indicated that it inhibited the output of H2 gas from T vaginalis before that of CO,, which parallels cell death, indicating that H2 inhibition is a primary effect. 14 19 implies that entry into aerobic cells is more difficult than into anaerobes and is consequently a further factor in explaining the selective toxicity of nitroimidazoles. The second is that reduction of the nitro group is a necessary function of the drugs' cytotoxic action.
The question remains however: if reduction of the drugs via the phosphoroclastic system is not the lethal event in the cell, what is? It becomes a logical hypothesis to propose that the biochemical lesion is caused not by the original drug molecule but by a reduction product or products which act at another site. The reduction of nitroimidazoles is merely an activation mechanism therefore which only anaerobes can carry out.
Site of action
Although protein has been suggested as a possible site of action of these drugs on the basis that about 30% of labelled metronidazole binds to intracellular components, the distribution of which parallels that of protein,20 no evidence has been published to suggest that any important protein system is inhibited. Instead, evidence has accumulated over the last few years since the suggestion of Ings et al'9 that DNA is the major site of action of nitroimidazoles.
Ings' initial observations showed that DNA synthesis in T vaginalis was inhibited as measured by incorporation of '4C-labelled thymidine into perchlorate-precipitable material in both the protozoan and in Clostridia. This work was subsequently corroborated and extended in our laboratory and showed that DNA synthesis was not only inhibited but existing DNA was broken down in Clostridia, and DNA could not be extracted from drug-treated Trichomonas figure) . The overall mechanism of action of all these drugs therefore is to decrease the stability and integrity of DNA by strand breakage.
Metronidazole and misonidazole are presently being evaluated as radio-sensitisers of hypoxic tumours,31 and the process of radiosensitisation has been extensively studied. This process has many features in common with the cytotoxic properties of nitroimidazoles, including the parameters of nitrogroup reduction and DNA strand breakage. Where the processes appear to differ is in the speed and temperature dependence. Thus radiosensitisation is a fast process (about 10-30 milliseconds) as is radiation damage (10 milliseconds) compared with radioprotection mechanisms (850 milliseconds) and cytotoxic effects (about I second) and is temperatureindependent, whereas cytotoxicity is relatively slow and temperature-dependent. It is now well established that the damaging agent of nitroimidazoles as radiosensitisers is the radical anion (-NO 2) since the efficiency of radiosensitisation of nitroimidazoles can be correlated with their oneelectron redox potentials.32 33 However, if the efficiency of strand-breakage of DNA in an electrolytic reduction in-vitro system is compared with the one-electron redox potential or the polarographic half-wave potential no obvious correlation exists27 indicating that the cytotoxic effect towards anaerobes is not due to the nitro radical anion. Recent observations in our laboratory30 show that reduced nitroimidazole-induced damage of DNA can be prevented by certain aminothiols, notably cysteamine and cystamine, and that cysteamine acts as a radical scavenger whereas cystamine does not but behaves as a radioprotector. This leads to the conclusion that the reduced agent responsible for DNA damage is at least further reduced beyond the radical anion stage. Precisely what this agent is has not been established yet because of its (their) inherent instability and short half-life. However, the implications of this cytotoxic agent are important for the anticancer action of the drugs since it has been established that the killing effect of the drugs in conjunction with radiation is greater than can be accounted for by radiosensitisation alone. The evidence for this comes from studies in which both normal (oxic) and hypoxic tumour cells are killed. 34 Since the radiosensitisation effect occurs only in hypoxic cells the killing of oxic cells can only be accounted for by a cytotoxic mechanism which does not involve free radicals.
The model electrolytic reduction system is applicable therefore for the study of both the mechanisms of cytotoxicity in anaerobes and in hypoxic cells.
Molecular basis of selective toxicity
Studies of the relative damage done by a number of nitroimidazoles results in two important characteristics of drug action. The first is that the amount of damage varies with the base composition of DNA and the second is that the amount of protection afforded by cysteamine depends on the redox potential of the drug. This latter point is important since the efficiency of action on DNA depends on the degree of strand breakage and aminothiol protection within the cell.
As regards the base composition of DNAs, it can be shown that damage is directly proportional to the A + T content irrespective of what technique is used to measure DNA damage (Edwards et al, unpublished observation) and that, using a variety of chromatographic techniques, it appears that thymidine phosphates are specifically released from DNA (Knox et al, unpublished observations). These results also argue against a free radical being responsible for such selective DNA damage. Precisely how specific thymidine phosphate release is achieved is not known and will require the elucidation of the active intermediate before this process is understood, but it does enable a molecular basis of selective toxicity to be formulated. Thus, one would expect nitroimidazoles to be particularly selectively toxic to anaerobic organisms which have A + T-rich DNAs and somewhat less so in G + Crich organisms. The protozoans, T vaginalis and Entamoeba histolytica, have A + T contents of 71 % and 62-78% respectively35-38 and Bacteroides have A + T contents of about 59-61 %. These organisms are the main causes of disease for which nitroimidazole drugs have major clinical application. In contrast, Rhodospirillum and R acidophila have relatively low A + T contents (38%7o and 33070 respectively) and these organisms are about 25 times less susceptible to nitroimidazoles than the protozoa or bacteria based on relative MICs. The implications of this will be discussed in detail elsewhere, but it is obvious that the particular effectiveness of such A + T-specific drugs against A + T-rich DNA is highly germane to their spectrum of activity or taxonomic specificity. ' 
